| |  Online-Ressource |
|---|
| Verfasst von: | Liebers, Nora [VerfasserIn]  |
|---|
| | Speer, Claudius [VerfasserIn] |
|---|
| | Benning, Louise [VerfasserIn] |
|---|
| | Bruch, Peter-Martin [VerfasserIn] |
|---|
| | Krämer, Isabelle [VerfasserIn] |
|---|
| | Meißner, Julia [VerfasserIn] |
|---|
| | Schnitzler, Paul [VerfasserIn] |
|---|
| | Kräusslich, Hans-Georg [VerfasserIn] |
|---|
| | Dreger, Peter [VerfasserIn] |
|---|
| | Müller-Tidow, Carsten [VerfasserIn] |
|---|
| | Poschke, Isabel [VerfasserIn] |
|---|
| | Dietrich, Sascha [VerfasserIn] |
|---|
| Titel: | Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients |
|---|
| Verf.angabe: | Nora Liebers, Claudius Speer, Louise Benning, Peter-Martin Bruch, Isabelle Kraemer, Julia Meissner, Paul Schnitzler, Hans-Georg Kräusslich, Peter Dreger, Carsten Mueller-Tidow, Isabel Poschke, and Sascha Dietrich |
|---|
| Jahr: | 2022 |
|---|
| Umfang: | 6 S. |
|---|
| Fussnoten: | Prepublished online on Blood first edition 20 October 2021 ; Gesehen am 16.09.2022 |
|---|
| Titel Quelle: | Enthalten in: Blood |
|---|
| Ort Quelle: | Washington, DC : American Society of Hematology, 1946 |
|---|
| Jahr Quelle: | 2022 |
|---|
| Band/Heft Quelle: | 139(2022), 1, Seite 142-147 |
|---|
| ISSN Quelle: | 1528-0020 |
|---|
| Abstract: | TO THE EDITOR:Patients with hematological neoplasms, including lymphoma patients, have a high risk for severe COVID-19 diseases.1-4 COVID-19 vaccinations induce strong serologic and T-cell responses in immunocompetent humans and thereby effectively prevent severe COVID-19 disease courses.5-8 There is accumulating evidence that humoral immune responses after vaccination are impaired in patients with hematological malignancies, especially if they were treated with B-cell-depleting therapies such as anti-CD20 antibodies.9-11 However, there is limited information about the T-cell-mediated vaccine responses after anti-CD20 treatment. In this study, we investigated the humoral and cellular responses after COVID-19 vaccination in lymphoma patients who had received anti-CD20 treatment. |
|---|
| DOI: | doi:10.1182/blood.2021013445 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1182/blood.2021013445 |
|---|
| | DOI: https://doi.org/10.1182/blood.2021013445 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| K10plus-PPN: | 181681556X |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients / Liebers, Nora [VerfasserIn]; 2022 (Online-Ressource)
